The University of Chicago Header Logo

Connection

Steven Chmura to Antineoplastic Agents, Alkylating

Back to Details
This is a "connection" page, showing publications Steven Chmura has written about Antineoplastic Agents, Alkylating.
Steven Chmura
Connection Strength
0.127
Antineoplastic Agents, Alkylating
  1. A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study. J Neurooncol. 2016 Jan; 126(2):309-16.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.